Literature DB >> 20734934

Preparative separation of four major bufadienolides from the Chinese traditional medicine, Chansu, using high-speed counter-current chromatography.

Xiu Lan Xin1, Junying Liu, Xiao Chi Ma, Qing Wei, Li Lv, Chang Yuan Wang, Ji Hong Yao, Jian Cui.   

Abstract

A preparative, high-speed, counter-current chromatographic (HSCCC) method for the isolation and purification of bufadienolides from Chansu was successfully developed by using stepwise elution with a two-phase solvent system composed of n-hexane: chloroform: methanol: water (4:1:2.5:5 and 4:1:4:5, v/v). A total of 7.5 mg of cinobufotalin (1), 8.0 mg of bufalin (2), 14.0 mg of cinobufagin (3) and 9.5 mg of resibufogenin (4) were obtained in a one-step separation from 80 mg of the crude extract with purities of 93.2%, 98.7%, 99.2%, and 99.4%, respectively. The chemical structures were determined from 1H NMR and 13C NMR spectroscopic data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734934

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  2 in total

1.  Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling.

Authors:  Syeda H Afroze; Jenna Sloan; Grace-Ann C Osuji; Nathan Drever; Kimberly Pilkinton; David C Zawieja; Thomas J Kuehl; M Nasir Uddin
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

2.  Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway.

Authors:  Ning Tang; Lei Shi; Zhenlong Yu; Peipei Dong; Chao Wang; Xiaokui Huo; Baojing Zhang; Shanshan Huang; Sa Deng; Kexin Liu; Tonghui Ma; Xiaobo Wang; Lijun Wu; Xiao-Chi Ma
Journal:  Oncotarget       Date:  2016-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.